The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
The FDA has granted breakthrough therapy designation to Novartis’ ianalumab for Sjögren’s disease, according to a press release from the manufacturer.In its statement, Novartis said it plans to submit ...
The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Businesses, schools, houses of faith, and non-profit organizations that engage the well-being of their employees, are transforming the state into a place where everyone can enjoy a healthy future.
In February 2021, less than a month into his presidential term, US President Joe Biden formally delisted Yemen’s Houthis both as a “Foreign Terrorist Organization” (FTO) and as “Specially Designated ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Ridofranz /Getty Image As with most other ...
FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results